186 related articles for article (PubMed ID: 27473817)
21. Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States.
Stokes WA; Amini A; Jackson MW; Plimpton SR; Kounalakis N; Kabos P; Rabinovitch RA; Rusthoven CG; Fisher CM
Clin Breast Cancer; 2018 Jun; 18(3):220-228. PubMed ID: 28797765
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
23. Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database.
Kang MM; Hasan Y; Waller J; Saulsberry L; Huo D
Clin Breast Cancer; 2022 Jan; 22(1):e8-e20. PubMed ID: 34257001
[TBL] [Abstract][Full Text] [Related]
24. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.
Schonberg MA; Marcantonio ER; Li D; Silliman RA; Ngo L; McCarthy EP
J Clin Oncol; 2010 Apr; 28(12):2038-45. PubMed ID: 20308658
[TBL] [Abstract][Full Text] [Related]
26. Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity.
Palumbo I; Mariucci C; Falcinelli L; Perrucci E; Lancellotta V; Podlesko AM; Marcantonini M; Saldi S; Bini V; Aristei C
Breast Cancer; 2019 May; 26(3):290-304. PubMed ID: 30341747
[TBL] [Abstract][Full Text] [Related]
27. Trends in the treatment of ductal carcinoma in situ of the breast.
Baxter NN; Virnig BA; Durham SB; Tuttle TM
J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
[TBL] [Abstract][Full Text] [Related]
28. Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis.
Kim DY; Park E; Heo CY; Jin US; Kim EK; Han W; Shin KH; Kim IA
Breast; 2021 Feb; 55():37-44. PubMed ID: 33316582
[TBL] [Abstract][Full Text] [Related]
29. Increased use of partial-breast irradiation has not improved radiotherapy utilization for early-stage breast cancer.
Billar JA; Sim MS; Chung M
Ann Surg Oncol; 2014 Dec; 21(13):4144-51. PubMed ID: 24969442
[TBL] [Abstract][Full Text] [Related]
30. Real-World Use of Hypofractionated Radiotherapy for Primary CNS Tumors in the Elderly, and Implications on Medicare Spending.
Tringale KR; Lin A; Miller AM; Khan A; Chen L; Zinovoy M; Yamada Y; Yu Y; Pike LRG; Imber BS
J Natl Compr Canc Netw; 2024 Apr; 22(4):. PubMed ID: 38688308
[TBL] [Abstract][Full Text] [Related]
31. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
[TBL] [Abstract][Full Text] [Related]
32. The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer.
Rutter CE; Lester-Coll NH; Mancini BR; Corso CD; Park HS; Yeboa DN; Gross CP; Evans SB
Cancer; 2015 Jul; 121(14):2331-40. PubMed ID: 25810128
[TBL] [Abstract][Full Text] [Related]
33. Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer.
Greenup RA; Blitzblau RC; Houck KL; Sosa JA; Horton J; Peppercorn JM; Taghian AG; Smith BL; Hwang ES
J Oncol Pract; 2017 Apr; 13(4):e283-e290. PubMed ID: 28291382
[TBL] [Abstract][Full Text] [Related]
34. Choosing wisely? Patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan.
Jagsi R; Griffith KA; Heimburger D; Walker EM; Grills IS; Boike T; Feng M; Moran JM; Hayman J; Pierce LJ;
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1010-6. PubMed ID: 25539366
[TBL] [Abstract][Full Text] [Related]
35. Socioeconomic status and breast cancer treatment.
Dreyer MS; Nattinger AB; McGinley EL; Pezzin LE
Breast Cancer Res Treat; 2018 Jan; 167(1):1-8. PubMed ID: 28884392
[TBL] [Abstract][Full Text] [Related]
36. The Pattern of Use of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer in New South Wales, Australia, 2008 to 2012.
Delaney GP; Gandhidasan S; Walton R; Terlich F; Baker D; Currow D
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):266-272. PubMed ID: 27473814
[TBL] [Abstract][Full Text] [Related]
37. Update on Accelerated Whole Breast Irradiation.
Shah C; Fleming-Hall E; Asha W
Clin Breast Cancer; 2023 Apr; 23(3):237-240. PubMed ID: 36792457
[TBL] [Abstract][Full Text] [Related]
38. Dissemination of clinical results. Mastectomy versus lumpectomy and radiation therapy.
Young WW; Marks SM; Kohler SA; Hsu AY
Med Care; 1996 Oct; 34(10):1003-17. PubMed ID: 8843927
[TBL] [Abstract][Full Text] [Related]
39. Outcomes Following a Moderately Hypofractionated Adjuvant Radiation (START B Type) Schedule for Breast Cancer in an Unscreened Non-Caucasian Population.
Chatterjee S; Arunsingh M; Agrawal S; Dabkara D; Mahata A; Arun I; Shrimali RK; Achari R; Mallick I; Ahmed R
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):e165-72. PubMed ID: 27369459
[TBL] [Abstract][Full Text] [Related]
40. Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients.
Wheeler SB; Carpenter WR; Peppercorn J; Schenck AP; Weinberger M; Biddle AK
Breast Cancer Res Treat; 2012 May; 133(1):333-45. PubMed ID: 22270934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
